# Microcurrent Stimulation Therapy for Nonexudative Age-related Macular Degeneration (i-SIGHT)

> **NCT05447650** · NA · COMPLETED · sponsor: **i-Lumen Scientific, Inc.** · enrollment: 95 (actual)

## Conditions studied

- Age-Related Macular Degeneration
- Dry Age-related Macular Degeneration
- Nonexudative Age-related Macular Degeneration

## Interventions

- **DEVICE:** i-Lumen(TM) AMD
- **DEVICE:** i-Lumen(TM) AMD Sham

## Key facts

- **NCT ID:** NCT05447650
- **Lead sponsor:** i-Lumen Scientific, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-04-12
- **Primary completion:** 2025-06-15
- **Final completion:** 2025-06-15
- **Target enrollment:** 95 (ACTUAL)
- **Last updated:** 2025-06-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05447650

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05447650, "Microcurrent Stimulation Therapy for Nonexudative Age-related Macular Degeneration (i-SIGHT)". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT05447650. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*